Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
Immunocompromised patients are at increased risk of complications of influenza virus infection. We report on two critically ill patients on immunosuppressive medication with influenza pneumonia. In both patients, oseltamivir monotherapy did not result in clearance of the virus after 18 and five days...
Saved in:
Main Authors: | Wouter J. Meijer, Wiete Kromdijk, Marcel P. H. van den Broek, Pieter-Jan A. Haas, Monique C. Minnema, Charles A. Boucher, Dylan W. de Lange, Annemarie M. J. Wensing |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2015/504975 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ode to Oseltamivir and Amantadine?
by: JM Conly, et al.
Published: (2006-01-01) -
Impact of Oseltamivir and Diabetes Development
by: Bor-Show Tzang, et al.
Published: (2025-01-01) -
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO
by: Giuseppe Gristina, et al.
Published: (2010-01-01) -
Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection
by: Koji Yokoyama, et al.
Published: (2023-01-01) -
Use of amantadine in traumatic brain injury: an updated meta-analysis of randomized controlled trials
by: João Félix, et al.
Published: (2025-01-01)